ArticleMolecular cancer therapeutics2022

Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts.

Vania Vidimar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.